Recombinant protein polymer-antibody conjugates for applications in nanotechnology and biomedicine

Awwad, 2018, Overview of Antibody Drug Delivery, Pharmaceutics, 10, 83, 10.3390/pharmaceutics10030083 Holliger, 2005, Engineered antibody fragments and the rise of single domains, Nat. Biotechnol., 23, 1126, 10.1038/nbt1142 Li, 2019, Recent progress in drug delivery, Acta Pharmaceutica Sinica B, 9, 1145, 10.1016/j.apsb.2019.08.003 Meibohm, 2012, Characterizing the impact of renal impairment on the clinical pharmacology of biologics, J. Clin. Pharmacol., 52, 54S, 10.1177/0091270011413894 Davis, 2002, The origin of pegnology, Adv. Drug Deliv. Rev., 54, 457, 10.1016/S0169-409X(02)00021-2 Yadav, 2021, PEGYLATION: an important approach for novel drug delivery system, J. Biomater. Sci. Polym. Ed., 32, 266, 10.1080/09205063.2020.1825304 Armstrong, 2007, Antibody against poly(ethylene glycol) adversely affects PEG-asparaginase therapy in acute lymphoblastic leukemia patients, Cancer, 110, 103, 10.1002/cncr.22739 I.A. Ivens, W. Achanzar, A. Baumann, A. Brändli-Baiocco, J. Cavagnaro, M. Dempster, B.O. Depelchin, A.R. Irizarry Rovira, L. Dill-Morton, J.H. Lane, B.M. Reipert, T. Salcedo, B. Schweighardt, L.S. Tsuruda, P.L. Turecek, J. Sims, PEGylated Biopharmaceuticals: Current Experience and Considerations for Nonclinical Development, Toxicologic Pathology, 43 (2015) 959-983. Fenton, 2018, Advances in biomaterials for drug delivery, Adv. Mater., 30, 1705328, 10.1002/adma.201705328 Gao, 2006, Fabrication of antibody arrays using thermally responsive elastin fusion proteins, J. Am. Chem. Soc., 128, 676, 10.1021/ja056364e Chambre, 2020, Bioengineered elastin- and silk-biomaterials for drug and gene delivery, Adv. Drug Deliv. Rev., 160, 186, 10.1016/j.addr.2020.10.008 Elvin, 2005, Synthesis and properties of crosslinked recombinant pro-resilin, Nature, 437, 999, 10.1038/nature04085 Picker, 2022, Prokaryotic collagen-like proteins as novel biomaterials, Front. Bioeng. Biotechnol., 10, 10.3389/fbioe.2022.840939 Schellenberger, 2009, A recombinant polypeptide extends the in vivo half-life of peptides and proteins in a tunable manner, Nat. Biotechnol., 27, 1186, 10.1038/nbt.1588 Schlapschy, 2013, PASylation: a biological alternative to PEGylation for extending the plasma half-life of pharmaceutically active proteins, Protein Eng. Des. Sel., 26, 489, 10.1093/protein/gzt023 Fletcher, 2012, A basis set of de novo coiled-coil peptide oligomers for rational protein design and synthetic biology, ACS Synth. Biol., 1, 240, 10.1021/sb300028q Varanko, 2020, Recent trends in protein and peptide-based biomaterials for advanced drug delivery, Adv. Drug Deliv. Rev., 156, 133, 10.1016/j.addr.2020.08.008 Weitzhandler, 2017, Micellar self-assembly of recombinant resilin-/elastin-like block copolypeptides, Biomacromolecules, 18, 2419, 10.1021/acs.biomac.7b00589 Almagro, 2018, Progress and challenges in the design and clinical development of antibodies for cancer therapy, Front. Immunol., 8, 10.3389/fimmu.2017.01751 Mullard, 2021, FDA approves 100th monoclonal antibody product, Nat. Rev. Drug Discovery, 20, 491, 10.1038/d41573-021-00079-7 S.L. Smith, Ten years of Orthoclone OKT3 (muromonab-CD3): a review, Journal of transplant coordination : official publication of the North American Transplant Coordinators Organization (NATCO), 6 (1996) 109-119; quiz 120-101. Elgundi, 2017, The state-of-play and future of antibody therapeutics, Adv. Drug Deliv. Rev., 122, 2, 10.1016/j.addr.2016.11.004 Lu, 2020, Development of therapeutic antibodies for the treatment of diseases, J. Biomed. Sci., 27, 1, 10.1186/s12929-019-0592-z Labrijn, 2019, Bispecific antibodies: a mechanistic review of the pipeline, Nat. Rev. Drug Discovery, 18, 585, 10.1038/s41573-019-0028-1 Hu, 2017, Nanobody-based delivery systems for diagnosis and targeted tumor therapy, Front. Immunol., 8, 10.3389/fimmu.2017.01442 Lee, 2020, Live long and active: Polypeptide-mediated assembly of antibody variable fragments, Adv. Drug Deliv. Rev., 167, 1, 10.1016/j.addr.2020.10.017 Jin, 2022, Emerging new therapeutic antibody derivatives for cancer treatment, Signal Transduction and Targeted Therapy, 7, 39, 10.1038/s41392-021-00868-x Peer, 2007, Nanocarriers as an emerging platform for cancer therapy, Nat. Nanotechnol., 2, 751, 10.1038/nnano.2007.387 Deyev, 2008, Multivalency: the hallmark of antibodies used for optimization of tumor targeting by design, BioEssays, 30, 904, 10.1002/bies.20805 Welch, 2017, Orientation and characterization of immobilized antibodies for improved immunoassays, Biointerphases, 12, 10.1116/1.4978435 Cui, 2018, Biotinylated single-chain variable fragment-based enzyme-linked immunosorbent assay for glycocholic acid, Analyst, 143, 2057, 10.1039/C7AN02024D Skerra, 1993, Bacterial expression of immunoglobulin fragments, Curr. Opin. Immunol., 5, 256, 10.1016/0952-7915(93)90014-J Fang, 2016, Structurally defined αMHC-II nanobody-drug conjugates: a therapeutic and imaging system for B-cell lymphoma, Angew. Chem. – Int. Ed., 55, 2416, 10.1002/anie.201509432 Ta, 2015, An efficient protocol towards site-specifically clickable nanobodies in high yield: Cytoplasmic expression in Escherichia coli combined with intein-mediated protein ligation, Protein Eng. Des. Sel., 28, 351, 10.1093/protein/gzv032 Muyldermans, 2001, Recognition of antigens by single-domain antibody fragments: the superfluous luxury of paired domains, Trends Biochem. Sci., 26, 230, 10.1016/S0968-0004(01)01790-X Skrlec, 2015, Non-immunoglobulin scaffolds: a focus on their targets, Trends Biotechnol., 33, 408, 10.1016/j.tibtech.2015.03.012 Lofblom, 2010, Affibody molecules: Engineered proteins for therapeutic, diagnostic and biotechnological applications, FEBS Lett., 584, 2670, 10.1016/j.febslet.2010.04.014 Deuschle, 2021, Anticalin® proteins: from bench to bedside, Expert Opin. Biol. Ther., 21, 509, 10.1080/14712598.2021.1839046 Paterson, 2014, Enzyme-mediated site-specific bioconjugation of metal complexes to proteins: Sortase-mediated coupling of copper-64 to a single-chain antibody, Angew. Chem. – Int. Ed., 53, 6115, 10.1002/anie.201402613 Sun, 2014, Engineered Nanoparticles for Drug Delivery in Cancer Therapy, Angew. Chem. – Int. Ed., 53, 12320, 10.1002/anie.201403036 Gray, 2014, Combinatorial Peptide Libraries: Mining for Cell-Binding Peptides, Chem. Rev., 114, 1020, 10.1021/cr400166n Bjorck, 1984, Purification and some properties of streptococcal protein-g, protein-a novel IGG-binding reagent, J. Immunol., 133, 969, 10.4049/jimmunol.133.2.969 Richman, 1982, The binding of staphylococcal protein-a by the sera of different animal species, J. Immunol., 128, 2300, 10.4049/jimmunol.128.5.2300 Kim, 2005, Temperature-triggered purification of antibodies, Biotechnol. Bioeng., 90, 373, 10.1002/bit.20451 Deisenhofer, 1981, Crystallographic refinement and atomic models of a human fc fragment and its complex with fragment-b of protein-a from staphylococcus-aureus at 2.9-a and 2.8-a resolution, Biochemistry, 20, 2361, 10.1021/bi00512a001 Sauereriksson, 1995, Crystal-structure of the c2 fragment of streptococcal protein-g in complex with the fc domain of human-IGG, Structure, 3, 265, 10.1016/S0969-2126(01)00157-5 Nilsson, 1987, A synthetic IGG-binding domain based on staphylococcal protein-a, Protein Eng., 1, 107, 10.1093/protein/1.2.107 Graille, 2000, Crystal structure of a Staphylococcus aureus protein A domain complexed with the Fab fragment of a human IgM antibody: Structural basis for recognition of B-cell receptors and superantigen activity, PNAS, 97, 5399, 10.1073/pnas.97.10.5399 Madan, 2013, ELP-z and ELP-zz capturing scaffolds for the purification of immunoglobulins by affinity precipitation, J. Biotechnol., 163, 10, 10.1016/j.jbiotec.2012.10.007 Swartz, 2017, Ligand-induced cross-linking of Z-elastin-like polypeptide-functionalized E2 protein nanoparticles for enhanced affinity precipitation of antibodies, Biomacromolecules, 18, 1654, 10.1021/acs.biomac.7b00275 Hartzell, 2020, Modular hepatitis B virus-like particle platform for biosensing and drug delivery, ACS Nano, 14, 12642, 10.1021/acsnano.9b08756 Choe, 2016, Fc-binding ligands of immunoglobulin G: An overview of high affinity proteins and peptides, Materials, 9, 17, 10.3390/ma9120994 Jung, 2008, Controlled antibody immobilization onto immunoanalytical platforms by synthetic peptide, Anal. Biochem., 374, 99, 10.1016/j.ab.2007.10.022 Jeong, 2016, Protein binders specific for immunoglobulin g from different species for immunoassays and multiplex imaging, Anal. Chem., 88, 11938, 10.1021/acs.analchem.6b03851 Park, 2018, Peptide-directed photo-cross-linking for site-specific conjugation of IgG, Bioconjug. Chem., 29, 3240, 10.1021/acs.bioconjchem.8b00515 Urry, 1992, Hydrophobicity scale for proteins based on inverse temperature transitions, Biopolymers, 32, 1243, 10.1002/bip.360320913 Meyer, 2004, Quantification of the effects of chain length and concentration on the thermal behavior of elastin-like polypeptides, Biomacromolecules, 5, 846, 10.1021/bm034215n MacKay, 2010, Quantitative model of the phase behavior of recombinant pH-responsive elastin-like polypeptides, Biomacromolecules, 11, 2873, 10.1021/bm100571j Callahan, 2012, Triple stimulus-responsive polypeptide nanoparticles that enhance intratumoral spatial distribution, Nano Lett., 12, 2165, 10.1021/nl300630c Meyer, 1999, Purification of recombinant proteins by fusion with thermally-responsive polypeptides, Nat. Biotechnol., 17, 1112, 10.1038/15100 Liu, 2012, Engineering a high-affinity scaffold for non-chromatographic protein purification via intein-mediated cleavage, Biotechnol. Bioeng., 109, 2829, 10.1002/bit.24545 Swartz, 2018, One-step affinity capture and precipitation for improved purification of an industrial monoclonal antibody using Z-ELP functionalized nanocages, Biotechnol. Bioeng., 115, 423, 10.1002/bit.26467 Swartz, 2018, SpyTag/SpyCatcher Functionalization of E2 Nanocages with Stimuli Responsive Z-ELP Affinity Domains for Tunable Monoclonal Antibody Binding and Precipitation Properties, Bioconjug. Chem., 29, 3113, 10.1021/acs.bioconjchem.8b00458 Lieser, 2019, Controlled epidermal growth factor receptor ligand display on cancer suicide enzymes via unnatural amino acid engineering for enhanced intracellular delivery in breast cancer cells, Bioconjug. Chem., 30, 432, 10.1021/acs.bioconjchem.8b00783 Hartzell, 2021, Engineering a Blue Light Inducible SpyTag System, J. Am. Chem. Soc., 143, 8572, 10.1021/jacs.1c03198 Swartz, 2018, Rapid quantification of monoclonal antibody titer in cell culture harvests by antibody-induced Z-ELP-E2 nanoparticle cross-linking, Anal. Chem., 90, 14447, 10.1021/acs.analchem.8b04083 Saha, 2020, Engineering the architecture of elastin-like polypeptides: from unimers to hierarchical self-assembly, Adv. Therapeutics, 3, 10.1002/adtp.201900164 Zhao, 2017, An anti-programmed death-1 antibody (αPD-1) fusion protein that self-assembles into a multivalent and functional αPD-1 nanoparticle, Mol. Pharm., 14, 1494, 10.1021/acs.molpharmaceut.6b01021 Aluri, 2014, A hybrid protein-polymer nanoworm potentiates apoptosis better than a monoclonal antibody, ACS Nano, 8, 2064, 10.1021/nn403973g Dzuricky, 2019, Avidity and cell uptake of integrin-targeting polypeptide micelles is strongly shape-dependent, Nano Lett., 19, 6124, 10.1021/acs.nanolett.9b02095 Xia, 2011, Tunable self-assembly of genetically engineered silk–elastin-like protein polymers, Biomacromolecules, 12, 3844, 10.1021/bm201165h Willems, 2019, Inducible fibril formation of silk-elastin diblocks, ACS Omega, 4, 9135, 10.1021/acsomega.9b01025 Amiram, 2013, A depot-forming glucagon-like peptide-1 fusion protein reduces blood glucose for five days with a single injection, J. Control. Release, 172, 144, 10.1016/j.jconrel.2013.07.021 Nouri, 2015, Reducing the visibility of the vector/DNA nanocomplexes to the immune system by elastin-like peptides, Pharm. Res., 32, 3018, 10.1007/s11095-015-1683-5 Banskota, 2019, Long circulating genetically encoded intrinsically disordered zwitterionic polypeptides for drug delivery, Biomaterials, 192, 475, 10.1016/j.biomaterials.2018.11.012 Conrad, 2011, ELPylated anti-human TNF therapeutic single-domain antibodies for prevention of lethal septic shock, Plant Biotechnol. J., 9, 22, 10.1111/j.1467-7652.2010.00523.x Pille, 2017, Self-assembling VHH-elastin-like peptides for photodynamic nanomedicine, Biomacromolecules, 18, 1302, 10.1021/acs.biomac.7b00064 Lee, 2020, Adaptable antibody nanoworms designed for non-hodgkin lymphoma, Biomaterials, 262, 10.1016/j.biomaterials.2020.120338 Vaikari, 2020, Anti-CD99 scFv-ELP nanoworms for the treatment of acute myeloid leukemia, nanomedicine: nanotechnology, Biology and Medicine, 29 Park, 2020, Anti-FLT3 nanoparticles for acute myeloid leukemia: Preclinical pharmacology and pharmacokinetics, J. Control. Release, 324, 317, 10.1016/j.jconrel.2020.05.021 Aigner, 2018, Biomedical applications of recombinant silk-based materials, Adv. Mater., 30, 10.1002/adma.201704636 Gosline, 1999, The mechanical design of spider silks: From fibroin sequence to mechanical function, J. Exp. Biol., 202, 3295, 10.1242/jeb.202.23.3295 Sato, 2017, Development and validation of scFv-conjugated affinity silk protein for specific detection of carcinoembryonic antigen, Sci. Rep., 7, 16077, 10.1038/s41598-017-16277-6 Sato, 2012, Production of scFv-conjugated affinity silk powder by transgenic silkworm technology, PLoS ONE, 7, e34632, 10.1371/journal.pone.0034632 Sato, 2014, Production of scFv-conjugated affinity silk film and its application to a novel enzyme-linked immunosorbent assay, Sci. Rep., 4, 4080, 10.1038/srep04080 Yu, 2022, A novel silk fibroin protein–based fusion system for enhancing the expression of nanobodies in Escherichia coli, Appl. Microbiol. Biotechnol., 106, 1967, 10.1007/s00253-022-11857-7 Huang, 2017, Rational design and hierarchical assembly of a genetically engineered resilin-silk copolymer results in stiff hydrogels, ACS Biomater. Sci. Eng., 3, 1576, 10.1021/acsbiomaterials.7b00353 Chen, 2017, Fabrication of protein films from genetically engineered silk-elastin-like proteins by controlled cross-linking, ACS Biomater. Sci. Eng., 3, 335, 10.1021/acsbiomaterials.6b00794 Jensen, 2017, Silk-elastinlike protein polymers enhance the efficacy of a therapeutic glycosaminoglycan for prophylactic treatment of radiation-induced proctitis, J. Control. Release, 263, 46, 10.1016/j.jconrel.2017.02.025 Parker, 2019, Design of silk-elastin-like protein nanoparticle systems with mucoadhesive properties, J. Funct. Biomater., 10, 10.3390/jfb10040049 Jansson, 2016, Functionalized silk assembled from a recombinant spider silk fusion protein (Z-4RepCT) produced in the methylotrophic yeast Pichia pastoris, Biotechnol. J., 11, 687, 10.1002/biot.201500412 Florczak, 2014, Functionalized spider silk spheres as drug carriers for targeted cancer therapy, Biomacromolecules, 15, 2971, 10.1021/bm500591p Güler, 2019, VEGFR2-specific ligands based on affibody molecules demonstrate agonistic effects when tetrameric in the soluble form or immobilized via spider silk, ACS Biomater. Sci. Eng., 5, 6474, 10.1021/acsbiomaterials.9b00994 Kumari, 2018, Recombinant spider silk hydrogels for sustained release of biologicals, ACS Biomater. Sci. Eng., 4, 1750 Jansson, 2014, Recombinant spider silk genetically functionalized with affinity domains, Biomacromolecules, 15, 1696, 10.1021/bm500114e Horak, 2018, Recombinant spider silk as mediator for one-step, chemical-free surface biofunctionalization, Adv. Funct. Mater., 28, 11, 10.1002/adfm.201800206 Thatikonda, 2016, Genetic fusion of single-chain variable fragments to partial spider silk improves target detection in micro- and nanoarrays, Biotechnol. J., 11, 437, 10.1002/biot.201500297 Mottaghitalab, 2017, Targeted delivery system based on gemcitabine-loaded silk fibroin nanoparticles for lung cancer therapy, ACS Appl. Mater. Interfaces, 9, 31600, 10.1021/acsami.7b10408 Florczak, 2020, Functionalized silk spheres selectively and effectively deliver a cytotoxic drug to targeted cancer cells in vivo, J. Nanobiotechnol., 18, 177, 10.1186/s12951-020-00734-y Kucharczyk, 2020, Drug affinity and targeted delivery: double functionalization of silk spheres for controlled doxorubicin delivery into Her2-positive cancer cells, J. Nanobiotechnol., 18, 56, 10.1186/s12951-020-00609-2 Kozlowska, 2017, Functionalized bioengineered spider silk spheres improve nuclease resistance and activity of oligonucleotide therapeutics providing a strategy for cancer treatment, Acta Biomater., 59, 221, 10.1016/j.actbio.2017.07.014 Numata, 2011, Spider silk-based gene carriers for tumor cell-specific delivery, Bioconjug. Chem., 22, 1605, 10.1021/bc200170u Kucharczyk, 2021, Hyperthermia treatment of cancer cells by the application of targeted silk/iron oxide composite spheres, Mater. Sci. Eng., C, 120, 10.1016/j.msec.2020.111654 Balu, 2014, Multi-responsive biomaterials and nanobioconjugates from resilin-like protein polymers, J. Mater. Chem. B, 2, 5936, 10.1039/C4TB00726C Qin, 2012, Mechanism of resilin elasticity, Nat. Commun., 3, 1003, 10.1038/ncomms2004 Li, 2013, Resilin-based materials for biomedical applications, ACS Macro Lett., 2, 635, 10.1021/mz4002194 Bailey, 1961, Amino acid composition of a new rubber-like protein, resilin, BBA, 48, 452 Ardell, 2001, Tentative identification of a resilin gene in Drosophila melanogaster, Insect Biochem. Mol. Biol., 31, 965, 10.1016/S0965-1748(01)00044-3 Lyons, 2012, Purification of recombinant protein by cold-coacervation of fusion constructs incorporating resilin-inspired polypeptides, Biotechnol. Bioeng., 109, 2947, 10.1002/bit.24565 Dutta, 2011, A genetically engineered protein responsive to multiple stimuli, Angew. Chem. Int. Ed., 50, 4428, 10.1002/anie.201007920 Li, 2015, Temperature-triggered phase separation of a hydrophilic resilin-like polypeptide, Macromol. Rapid Commun., 36, 90, 10.1002/marc.201400521 Canning, 2017, pH-responsive schizophrenic diblock copolymers prepared by polymerization-induced self-assembly, Macromolecules, 50, 6108, 10.1021/acs.macromol.7b01005 Charati, 2009, Hydrophilic elastomeric biomaterials based on resilin-like polypeptides, Soft Matter, 5, 3412, 10.1039/b910980c Renner, 2012, Characterization of resilin-based materials for tissue engineering applications, Biomacromolecules, 13, 3678, 10.1021/bm301129b Li, 2013, Resilin-like polypeptide hydrogels engineered for versatile biological function, Soft Matter, 9, 665, 10.1039/C2SM26812D Su, 2019, Redox-responsive resilin-like hydrogels for tissue engineering and drug delivery applications, Macromol. Biosci., 19, 1900122, 10.1002/mabi.201900122 Li, 2011, Tunable mechanical stability and deformation response of a resilin-based elastomer, Biomacromolecules, 12, 2302, 10.1021/bm200373p D'Andrea, 2005, Targeting angiogenesis: Structural characterization and biological properties of a de novo engineered VEGF mimicking peptide, Proc. Natl. Acad. Sci., 102, 14215, 10.1073/pnas.0505047102 Qin, 2009, Expression, cross-linking, and characterization of recombinant chitin binding resilin, Biomacromolecules, 10, 3227, 10.1021/bm900735g Bracalello, 2011, Design and production of a chimeric resilin-, elastin-, and collagen-like engineered polypeptide, Biomacromolecules, 12, 2957, 10.1021/bm2005388 Shoulders, 2009, Collagen structure and stability, Annu. Rev. Biochem., 78, 929, 10.1146/annurev.biochem.77.032207.120833 Boudko, 2008, Crystal structure of human type III collagen Gly991-Gly1032 cystine knot-containing peptide shows both 7/2 and 10/3 triple helical symmetries, J. Biol. Chem., 283, 32580, 10.1074/jbc.M805394200 Maeda, 1999, An atomic force microscopy study of ordered molecular assemblies and concentric ring patterns from evaporating droplets of collagen solutions, Langmuir, 15, 8505, 10.1021/la981738l Berisio, 2002, Crystal structure of the collagen triple helix model [(Pro-Pro-Gly)(10)](3), Protein Sci., 11, 262, 10.1110/ps.32602 Gelse, 2003, Collagens–structure, function, and biosynthesis, Adv. Drug Deliv. Rev., 55, 1531, 10.1016/j.addr.2003.08.002 Turner, 2015, The use of biologic scaffolds in the treatment of chronic nonhealing wounds, Adv. Wound Care (New Rochelle), 4, 490, 10.1089/wound.2014.0604 Chattopadhyay, 2014, Review collagen-based biomaterials for wound healing, Biopolymers, 101, 821, 10.1002/bip.22486 Ruszczak, 2003, Collagen as a carrier for on-site delivery of antibacterial drugs, Adv. Drug Deliv. Rev., 55, 1679, 10.1016/j.addr.2003.08.007 Orsi, 2010, Cell recruitment and transfection in gene activated collagen matrix, Biomaterials, 31, 570, 10.1016/j.biomaterials.2009.09.054 Xu, 2021, Collagen mimetic peptides, Bioengineering (Basel), 8 Wang, 2017, Production of recombinant collagen: state of the art and challenges, Eng. Biol., 1, 18, 10.1049/enb.2017.0003 Luo, 2017, Collagen-like peptide bioconjugates, Bioconjug. Chem., 28, 816, 10.1021/acs.bioconjchem.6b00673 Gorres, 2010, Prolyl 4-hydroxylase, Crit. Rev. Biochem. Mol. Biol., 45, 106, 10.3109/10409231003627991 Bretscher, 2001, Conformational stability of collagen relies on a stereoelectronic effect, J. Am. Chem. Soc., 123, 777, 10.1021/ja005542v Hodges, 2005, Stereoelectronic and steric effects in the collagen triple helix: toward a code for strand association, J. Am. Chem. Soc., 127, 15923, 10.1021/ja054674r M. Yamauchi, M. Shiiba, Lysine Hydroxylation and Cross-linking of Collagen, in: C. Kannicht (Ed.) Post-translational Modifications of Proteins: Tools for Functional Proteomics, Humana Press, Totowa, NJ, 2008, pp. 95-108. Ruggiero, 2008, Making recombinant extracellular matrix proteins, Methods, 45, 75, 10.1016/j.ymeth.2008.01.003 Buechter, 2003, Co-translational incorporation of trans-4-hydroxyproline into recombinant proteins in bacteria, J. Biol. Chem., 278, 645, 10.1074/jbc.M209364200 Pinkas, 2011, Tunable, post-translational hydroxylation of collagen Domains in Escherichia coli, ACS Chem. Biol., 6, 320, 10.1021/cb100298r Rutschmann, 2014, Recombinant expression of hydroxylated human collagen in Escherichia coli, Appl. Microbiol. Biotechnol., 98, 4445, 10.1007/s00253-013-5447-z Yu, 2014, Bacterial collagen-like proteins that form triple-helical structures, J. Struct. Biol., 186, 451, 10.1016/j.jsb.2014.01.003 Yu, 2010, Noncollagenous region of the streptococcal collagen-like protein is a trimerization domain that supports refolding of adjacent homologous and heterologous collagenous domains, Protein Sci., 19, 775, 10.1002/pro.356 Mohs, 2007, Mechanism of stabilization of a bacterial collagen triple helix in the absence of hydroxyproline, J. Biol. Chem., 282, 29757, 10.1074/jbc.M703991200 Yu, 2011, Dissecting a bacterial collagen domain from Streptococcus pyogenes: sequence and length-dependent variations in triple helix stability and folding, J. Biol. Chem., 286, 18960, 10.1074/jbc.M110.217422 Han, 2006, Assessment of prokaryotic collagen-like sequences derived from streptococcal Scl1 and Scl2 proteins as a source of recombinant GXY polymers, Appl. Microbiol. Biotechnol., 72, 109, 10.1007/s00253-006-0387-5 Yoshizumi, 2009, Self-association of streptococcus pyogenes collagen-like constructs into higher order structures, Protein Sci., 18, 1241, 10.1002/pro.134 Peng, 2012, Towards scalable production of a collagen-like protein from Streptococcus pyogenes for biomedical applications, Microb. Cell Factories, 11, 1, 10.1186/1475-2859-11-146 Peng, 2014, A simple cost-effective methodology for large-scale purification of recombinant non-animal collagens, Appl. Microbiol. Biotechnol., 98, 1807, 10.1007/s00253-013-5475-8 Peng, 2010, A Streptococcus pyogenes derived collagen-like protein as a non-cytotoxic and non-immunogenic cross-linkable biomaterial, Biomaterials, 31, 2755, 10.1016/j.biomaterials.2009.12.040 Fan, 2008, Production of multivalent protein binders using a self-trimerizing collagen-like peptide scaffold, FASEB J., 22, 3795, 10.1096/fj.08-111484 Cuesta, 2010, Multivalent antibodies: when design surpasses evolution, Trends Biotechnol., 28, 355, 10.1016/j.tibtech.2010.03.007 Jalan, 2013, Hydroxyproline-free single composition ABC collagen heterotrimer, J. Am. Chem. Soc., 135, 6014, 10.1021/ja402187t Jalan, 2013, Simultaneous control of composition and register of an AAB-type collagen heterotrimer, Biomacromolecules, 14, 179, 10.1021/bm3015818 Boudko, 2012, The NC2 domain of type IX collagen determines the chain register of the triple helix, J. Biol. Chem., 287, 44536, 10.1074/jbc.M112.417543 Fouet, 2021, Headless C1q: a new molecular tool to decipher its collagen-like functions, FEBS J., 288, 2030, 10.1111/febs.15543 Qi, 2015, Protein-polymer conjugation-moving beyond PEGylation, Curr. Opin. Chem. Biol., 28, 181, 10.1016/j.cbpa.2015.08.009 Kubetzko, 2005, Protein PEGylation decreases observed target association rates via a dual blocking mechanism, Mol. Pharmacol., 68, 1439, 10.1124/mol.105.014910 Brandl, 2019, Influence of size and charge of unstructured polypeptides on pharmacokinetics and biodistribution of targeted fusion proteins, J. Control. Release, 307, 379, 10.1016/j.jconrel.2019.06.030 Podust, 2016, Extension of in vivo half-life of biologically active molecules by XTEN protein polymers, J. Control. Release, 240, 52, 10.1016/j.jconrel.2015.10.038 Brandl, 2020, Optimizing the anti-tumor efficacy of protein-drug conjugates by engineering the molecular size and half-life, J. Control. Release, 327, 186, 10.1016/j.jconrel.2020.08.004 Binder, 2017, PASylation®: A versatile technology to extend drug delivery, Curr. Opin. Colloid Interface Sci., 31, 10, 10.1016/j.cocis.2017.06.004 Breibeck, 2018, The polypeptide biophysics of proline/alanine-rich sequences (PAS): Recombinant biopolymers with PEG-like properties, Biopolymers, 109, 10.1002/bip.23069 Mendler, 2015, High contrast tumor imaging with radio-labeled antibody Fab fragments tailored for optimized pharmacokinetics via PASylation, MAbs, 7, 96, 10.4161/19420862.2014.985522 Pfister, 2014, Process for protein PEGylation, J. Control. Release, 180, 134, 10.1016/j.jconrel.2014.02.002 Cleland, 2012, A novel long-acting human growth hormone fusion protein (VRS-317): enhanced in vivo potency and half-life, J. Pharm. Sci., 101, 2744, 10.1002/jps.23229 Ding, 2014, Multivalent antiviral XTEN-peptide conjugates with long in vivo half-life and enhanced solubility, Bioconjug. Chem., 25, 1351, 10.1021/bc500215m Zacharias, 2022, A homogeneous high-DAR antibody-drug conjugate platform combining THIOMAB antibodies and XTEN polypeptides, Chem. Sci., 13, 3147, 10.1039/D1SC05243H Nomani, 2021, Gadolinium-labeled affibody-XTEN recombinant vector for detection of HER2+ lesions of ovarian cancer lung metastasis using quantitative MRI, J. Control. Release, 337, 132, 10.1016/j.jconrel.2021.07.022 Haeckel, 2016, XTEN as biological alternative to PEGylation allows complete expression of a protease-activatable killin-based cytostatic, PLoS ONE, 11, e0157193, 10.1371/journal.pone.0157193 Schilz, 2022, Direct affinity purification of long-acting PASylated proteins with therapeutic potential using L-prolinamide for mild elution, Angew. Chem. Int. Ed. Engl., e202200079 Schilz, 2021, Molecular recognition of structurally disordered Pro/Ala-rich sequences (PAS) by antibodies involves an Ala residue at the hot spot of the epitope, J. Mol. Biol., 433, 10.1016/j.jmb.2021.167113 Mendler, 2015, (8)(9)Zr-Labeled Versus (1)(2)(4)I-Labeled alphaHER2 Fab with Optimized Plasma Half-Life for High-Contrast Tumor Imaging In Vivo, J. Nucl. Med., 56, 1112, 10.2967/jnumed.114.149690 Mendler, 2016, Tumor uptake of anti-CD20 fabs depends on tumor perfusion, J. Nucl. Med., 57, 1971, 10.2967/jnumed.116.176784 Mazaheri, 2020, Improvement of Certolizumab Fab' properties by PASylation technology, Sci. Rep., 10, 18464, 10.1038/s41598-020-74549-0 Richter, 2020, First in-human medical imaging with a PASylated (89)Zr-Labeled anti-HER2 fab-fragment in a patient with metastatic breast cancer, Nucl. Med. Mol. Imaging, 54, 114, 10.1007/s13139-020-00638-7 Peplau, 2020, Development of a chimeric antigen-binding fragment directed against human galectin-3 and validation as an immuno-positron emission tomography tracer for the sensitive in vivo imaging of thyroid cancer, Thyroid, 30, 1314, 10.1089/thy.2019.0670 Khodabakhsh, 2018, Development of a novel nano-sized anti-VEGFA nanobody with enhanced physicochemical and pharmacokinetic properties, Artif. Cells Nanomed. Biotechnol., 46, 1402, 10.1080/21691401.2017.1369426 Khodabakhsh, 2020, New proline, alanine, serine repeat sequence for pharmacokinetic enhancement of anti-VEGF single-domain antibody, J. Pharmacol. Exp. Ther., 375, 69, 10.1124/jpet.120.000012 Eggenstein, 2020, FluoroCalins: engineered lipocalins with novel binding functions fused to a fluorescent protein for applications in biomolecular imaging and detection, Protein Eng. Des. Sel., 32, 289, 10.1093/protein/gzz047 Deuschle, 2020, Development of a high affinity Anticalin((R)) directed against human CD98hc for theranostic applications, Theranostics, 10, 2172, 10.7150/thno.38968 Theocharopoulos, 2021, Antibody-drug conjugates: functional principles and applications in oncology and beyond, Vaccines (Basel), 9 M. To, P. Yeung, M. Fox, L. Liu, S. Khorsand, F. Cattaruzza, A. Nazeer, K. Morrissey, D.Rennerfeldt, Z. Lange,C. Koshi, M. Hammond, M. Dong, S. Lam, M.K. Derynck, B.A. Irving, V.Schellenberger, AMX-818, a Protease-Activated T Cell Engager Targeting HER2 with Potent TCell Activation, Proteolytic Cleavage and Efficacy in Xenograft Tumors, and Wide Safety Margins in Non-Human Primates, AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics, 2021. Cattaruzza, 2020, HER2-XPAT and EGFR-XPAT: Pro-Drug T Cell Engagers (TCEs) Engineered to Address On-Target, Off-Tumor Toxicity With Potent Efficacy invitro and in vivo and Large Safety Margins in NHP, AACR Virtual Annual Meeting II Gradišar, 2011, De novo design of orthogonal peptide pairs forming parallel coiled-coil heterodimers, J. Pept. Sci., 17, 100, 10.1002/psc.1331 Cristie-David, 2017, Evaluation of de novo-designed coiled coils as off-the-shelf components for protein assembly, Mol. Syst. Des. Eng., 2, 140, 10.1039/C7ME00012J Pandya, 2000, Sticky-end assembly of a designed peptide fiber provides insight into protein fibrillogenesis, Biochemistry, 39, 8728, 10.1021/bi000246g Boyle, 2012, Squaring the circle in peptide assembly: from fibers to discrete nanostructures by de novo design, J. Am. Chem. Soc., 134, 15457, 10.1021/ja3053943 Gradisar, 2013, Design of a single-chain polypeptide tetrahedron assembled from coiled-coil segments, Nat. Chem. Biol., 9, 362, 10.1038/nchembio.1248 Ryadnov, 2003, Engineering the morphology of a self-assembling protein fibre, Nat. Mater., 2, 329, 10.1038/nmat885 Park, 2014, Thermally triggered self-assembly of folded proteins into vesicles, J. Am. Chem. Soc., 136, 17906, 10.1021/ja5090157 Utterström, 2021, Coiled coil-based therapeutics and drug delivery systems, Adv. Drug Deliv. Rev., 170, 26, 10.1016/j.addr.2020.12.012 Zaccai, 2011, A de novo peptide hexamer with a mutable channel, Nat. Chem. Biol., 7, 935, 10.1038/nchembio.692 Lim, 2017, Self-assembled protein nanocarrier for intracellular delivery of antibody, J. Control. Release, 249, 1, 10.1016/j.jconrel.2017.01.007 Dhankher, 2021, Coiled coil exposure and histidine tags drive function of an intracellular protein drug carrier, J. Control. Release, 339, 248, 10.1016/j.jconrel.2021.09.026 A. Majerle, S. Hadži, J. Aupič, T. Satler, F. Lapenta, Ž. Strmšek, J. Lah, R. Loris, R. Jerala, A nanobody toolbox targeting dimeric coiled-coil modules for functionalization of designed protein origami structures, Proc. Natl. Acad. Sci. U. S. A., 118 (2021). Raman, 2006, Structure-based design of peptides that self-assemble into regular polyhedral nanoparticles, Nanomed. Nanotechnol. Biol. Med., 2, 95, 10.1016/j.nano.2006.04.007 Karch, 2019, Design and characterization of a self-assembling protein nanoparticle displaying HIV-1 Env V1V2 loop in a native-like trimeric conformation as vaccine antigen, Nanomed. Nanotechnol. Biol. Med., 16, 206, 10.1016/j.nano.2018.12.001 Karch, 2017, The use of a P. falciparum specific coiled-coil domain to construct a self-assembling protein nanoparticle vaccine to prevent malaria, J. Nanobiotechnol., 15, 62, 10.1186/s12951-017-0295-0 Despanie, 2016, Elastin-like polypeptides: Therapeutic applications for an emerging class of nanomedicines, J. Control. Release, 240, 93, 10.1016/j.jconrel.2015.11.010 Rondon, 2021, Protein engineering strategies for improved pharmacokinetics, Adv. Funct. Mater., 31, 2101633, 10.1002/adfm.202101633 Beck, 2017, Strategies and challenges for the next generation of antibody–drug conjugates, Nat. Rev. Drug Discovery, 16, 315, 10.1038/nrd.2016.268 Slastnikova, 2018, Targeted intracellular delivery of antibodies: the state of the art, Front. Pharmacol., 9, 10.3389/fphar.2018.01208 Zhang, 2021, Covalently engineered nanobody chimeras for targeted membrane protein degradation, J. Am. Chem. Soc., 143, 16377, 10.1021/jacs.1c08521 Yu, 2021, Efficient intracellular delivery of proteins by a multifunctional chimaeric peptide in vitro and in vivo, Nat. Commun., 12, 5131, 10.1038/s41467-021-25448-z FDA/CEDR resources page. Food and Drug Administration Web site. https://www.fda.gov/combination-products/guidance-regulatory-information/combination-products-guidance-documents. 01/28/2022. Zhang, 2015, A highly elastic and rapidly crosslinkable elastin-like polypeptide-based hydrogel for biomedical applications, Adv. Funct. Mater., 25, 4814, 10.1002/adfm.201501489 Merrett, 2021, Enhanced collagen-like protein for facile biomaterial fabrication, ACS Biomater. Sci. Eng., 7, 1414, 10.1021/acsbiomaterials.1c00069 Hu, 2021, Design strategies to tune the structural and mechanical properties of synthetic collagen hydrogels, Biomacromolecules, 22, 3440, 10.1021/acs.biomac.1c00520 Zhou, 2016, Rationally designed redox-sensitive protein hydrogels with tunable mechanical properties, Biomacromolecules, 17, 3508, 10.1021/acs.biomac.6b00973 Rombouts, 2015, Reversible temperature-switching of hydrogel stiffness of coassembled, silk-collagen-like hydrogels, Biomacromolecules, 16, 2506, 10.1021/acs.biomac.5b00766 Guziewicz, 2011, Lyophilized silk fibroin hydrogels for the sustained local delivery of therapeutic monoclonal antibodies, Biomaterials, 32, 2642, 10.1016/j.biomaterials.2010.12.023 Li, 2013, Targeting and mimicking collagens via triple helical peptide assembly, Curr. Opin. Chem. Biol., 17, 968, 10.1016/j.cbpa.2013.10.018 Luo, 2017, Thermoresponsive elastin-b-collagen-like peptide bioconjugate nanovesicles for targeted drug delivery to collagen-containing matrices, Biomacromolecules, 18, 2539, 10.1021/acs.biomac.7b00686 Dunshee, 2020, Manipulation of the dually thermoresponsive behavior of peptide-based vesicles through modification of collagen-like peptide domains, Bioeng. Transl. Med., 5, e10145, 10.1002/btm2.10145 Sun, 2015, Post-translational modification of bionanoparticles as a modular platform for biosensor assembly, ACS Nano, 9, 8554, 10.1021/acsnano.5b03688 Berckman, 2020, A modular approach for dCas9-mediated enzyme cascading via orthogonal bioconjugation, Chem. Commun., 10.1039/D0CC04196C Lieser, 2022, Incorporation of endosomolytic peptides with varying disruption mechanisms into EGFR-targeted protein conjugates: the effect on intracellular protein delivery and EGFR specificity in breast cancer cells, Mol. Pharm., 19, 661, 10.1021/acs.molpharmaceut.1c00788 Lieser, 2022, EGFR ligand clustering on E2 bionanoparticles for targeted delivery of chemotherapeutics to breast cancer cells, Bioconjug. Chem., 33, 452, 10.1021/acs.bioconjchem.1c00579 Berckman, 2021, Self-assembling protein nanocages for modular enzyme assembly by orthogonal bioconjugation, Biotechnol. Prog., 37, e3190, 10.1002/btpr.3190 Strohl, 2015, Fusion Proteins for half-life extension of biologics as a strategy to make biobetters, BioDrugs : Clin. Immunotherapeutics, Biopharmaceuticals and Gene Therapy, 29, 215, 10.1007/s40259-015-0133-6